2022 °æºÏ´ëÇб³º´¿ø À¯Àü¼º ¾Ï ½ÉÆ÷Áö¾ö (2022 KNUH Hereditary Cancer Symposium) : 2022-06-11±³À°ÀÏÀÚ : 2022-06-11
±³À°Àå¼Ò : Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç
±³À°ÁÖÁ¦ :
2022 °æºÏ´ëÇб³º´¿ø À¯Àü¼º ¾Ï ½ÉÆ÷Áö¾ö (2022 KNUH Hereditary Cancer Symposium)ÁÖÃÖ±â°ü : °æºÏ´ëÇб³º´¿ø
´ã´çÀÚ : ±ÝÈñÁ¤
¿¬¶ôó : 053-200-2719
À̸ÞÀÏ :
gold_hj@naver.com ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 13:00~13:10 Opening remark ¹ÚÈ£¿ë(Ä¥°î°æºÏ´ëÇб³º´¿ø ¿Ü°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 13:10~13:30 Standard and guideline for the interpretation of sequence variants in solid cancer ÃÖÁ¾¹®(³ì½ÊÀÚ Áö³ð)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 13:30~13:50 Laboratory experience of hereditary cancer syndrome ±èµµÈÆ(°è¸í´ëÇб³µ¿»êº´¿ø Áø´Ü°Ë»çÀÇÇаú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 13:50~14:10 Homologous recombination deficient in ovarian cancer ±è¹®½Ä(Ä¥°î°æºÏ´ëÇб³º´¿ø º´¸®°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 14:10~14:30 Germline BRCA test in KNUCH À̳¿µ(Ä¥°î°æºÏ´ëÇб³º´¿ø Áø´Ü°Ë»çÀÇÇаú)
Åä·Ð 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 14:30~14:40 Q & A Àüâȣ(´ë±¸°¡Å縯´ëÇб³º´¿ø Áø´Ü°Ë»çÀÇÇаú)
ÈÞ½Ä 06-11 14:40~14:50 Coffee Break ()
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 14:50~15:10 Perspectives on hereditary gynecologic cancer management È«´ë±â(Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 15:10~15:30 PARP inhibitors pave the way to cure in ovarian cancer ÀÌÀÎÈñ(Ä¥°î°æºÏ´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 15:30~15:50 Hereditary breast cancer in Korea (KOHBRA study) À¯Àç¹Î(»ï¼º¼¿ïº´¿ø ¿Ü°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 15:50~16:10 Risk reduction strategies for hereditary breast cancer ÀÌÁö¿¬(Ä¥°î°æºÏ´ëÇб³º´¿ø ¿Ü°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 16:10~16:30 Genetic counseling for BRCA carriers and blood relatives °º´ÁÖ(Ä¥°î°æºÏ´ëÇб³º´¿ø ¿Ü°ú)
Åä·Ð 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 16:30~16:40 Q & A äÀǼö/È«´ë±â(Ä¥°î°æºÏ´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú/»êºÎÀΰú)
ÈÞ½Ä 06-11 16:40~16:50 Coffee Break ()
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 16:50~17:10 Hereditary colorectal cancer syndorme : Genetics and clinical implication ±èÁø¿µ(°è¸í´ëÇб³µ¿»êº´¿ø Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 17:10~17:30 Surveillance and prevention strategies for hereditary colorectal cancer syndrome ÀÌÇö¼®(Ä¥°î°æºÏ´ëÇб³º´¿ø ¼Òȱ⳻°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 17:30~17:50 MMR and MSI test in hereditary colorectal cancer syndrome ¼¾È³ª(Ä¥°î°æºÏ´ëÇб³º´¿ø º´¸®°ú)
±³À°½Ã°£ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 17:50~18:10 Surgical treatment for hereditary colorectal cancer syndrome ±è´ö¿ì(ºÐ´ç¼¿ï´ëÇб³º´¿ø ¿Ü°ú)
Åä·Ð 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 18:10~18:20 Q & A ±èÁ¾±¤(Ä¥°î°æºÏ´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú)
±âŸ 06-11 Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç 18:20~18:30 Closing remark ±èÁ¾±¤(Ä¥°î°æºÏ´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú)